← Eichor
Study identifier: NCT05596539 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Prospective, Longitudinal, Observational Registry of Adult Patients With Hypophosphatasia (REG-HYPO)

Condition: Hypophosphatasia  ·  Sponsor: Assistance Publique - Hôpitaux de Paris

PhaseN/A
Planned participants130
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to assess medical events during follow-up of adult patients having hypophosphatasia and consulting rheumatologists.

This description comes directly from the study's public registry record.

Talk to the study team

Christian ROUX, MD, PhD  ·  0158412579  ·  christian.roux@aphp.fr

Valérie PLENCE, MSc  ·  0171760781/0158413478  ·  valerie.plence-fauroux@aphp.fr

Always discuss trial participation with your own doctor first.

Locations (11)

CHU de Bordeaux- Hôpital Pellegrin Place Amélia Raba Léon - 12è étage - Rhumatologie -Bordeaux, France, FranceNot Yet Recruiting
CHU LilleLille, FranceRecruiting
Hospices Civils de LyonLyon, FranceNot Yet Recruiting
CHU NiceNice, FranceRecruiting
Lariboisière HospitalParis, FranceRecruiting
Cochin HospitalParis, FranceRecruiting
CHU PoitiersPoitiers, FranceRecruiting
CHU RennesRennes, FranceRecruiting
CHU Saint-EtienneSaint-Priest-en-Jarez, FranceRecruiting
Les hôpitaux universitaires de StrasbourgStrasbourg, FranceRecruiting
CHU de ToulouseToulouse, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05596539